Pharmacists in Wasilla, AK Accepting Medicare

41 Pharmacists found. Showing 1 - 20

Mr. Uriah Josiah Clarkson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1721 E Parks Hwy, Wasilla, AK 99654 Phone: 907-631-0300    Fax: 907-631-0632

Amber L Ewart, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 E Parks Hwy, Wasilla, AK 99654 Phone: 907-631-7201

Sylvain Nouvion, PHARM.D., PH.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1721 E Parks Hwy, Wasilla, AK 99654 Phone: 907-631-0300

Kristin Martin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1801 E Parks Hwy, Wasilla, AK 99654 Phone: 907-631-7201    Fax: 907-631-7201

Dr. Stephen Charles Tarbell Ii, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1721 E. George Parks Hwy., Wasilla, AK 99654 Phone: 907-631-0300

Arlia Lau, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 S Knik Goose Bay Rd Ste 1100, Wasilla, AK 99654 Phone: 907-631-7392    Fax: 907-631-7619

Richard Mickelson, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1501 E Parks Hwy, Wasilla, AK 99654 Phone: 907-352-5033    Fax: 907-352-5027

Dr. Michael Enos Kawesa, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1721 E George Parks Highway, Wasilla, AK 99654 Phone: 907-631-0300

Dr. Brian K Barrett Jr., PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 S Knik Goose Bay Rd, Wasilla, AK 99654 Phone: 907-729-8961    Fax: 907-729-6353

Saniye Nur Zen Stevens, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1350 S Seward Meridian Pkwy, Wasilla, AK 99654 Phone: 907-376-9780

Robert Gorsline, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1721 E Parks Hwy, Wasilla, AK 99654 Phone: 907-631-0300

Alexander Goldin Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1721 E Parks Hwy, Wasilla, AK 99654 Phone: 907-631-0300

Dr. William Glen Decker, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3674 E Country Field Cir, Medset, Wasilla, AK 99654 Phone: 907-376-8200    Fax: 907-376-8195

Dr. Piper Jessica Marsh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1721 E George Parks Hwy, Wasilla, AK 99654 Phone: 907-631-0300    Fax: 907-631-0632

Elizabeth Johnson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1721 E Parks Hwy, Wasilla, AK 99654 Phone: 907-631-0300

Mackenzie E Lasnek, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1501 E Parks Hwy, Wasilla, AK 99654 Phone: 907-352-5033

Chad Gubler Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 595 E Parks Hwy, Wasilla, AK 99654 Phone: 907-352-1160

Matthew Thomsas Folcik Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1721 E Parks Hwy, Wasilla, AK 99654 Phone: 907-631-0300

Janet Lynn Schwartz, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 595 E Parks Highway #300, Carrs Pharmacy, Wasilla, AK 99687 Phone: 907-352-1160    Fax: 907-352-1119

Dr. Aislinn Mcbeth, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 595 E Parks Hwy, Suite 300, Wasilla, AK 99654 Phone: 907-352-1160

News Archive

Jumping genes: a marker for early cancer diagnosis? An interview with Dr Kazazian

In the genome of every human being, there are about 80-100 active LINE-1s that are capable of mobilizing by a copy and paste mechanism to a new location in the genome.

Measuring BMI can help predict diabetic patient's risk for heart disease

Researchers from the Intermountain Medical Center Heart Institute, in collaboration with researchers from Johns Hopkins University and the National Institutes of Health, have discovered a simple way to further predict a diabetic patient's risk for heart disease: by measuring their body mass index or BMI.

MicroRNAs hold promise as markers for bladder cancer prognosis

Researchers have found that microRNAs can be useful prognostic biomarkers for individuals with urothelial carcinoma.

FDA issues Complete Response Letter for Horizant in treatment of RLS

GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).

Read more Medical News

› Verified 3 days ago

• 1(current)
• 2
• 3